Only 15 percent of biomedical postdoctoral fellows will get jobs in the fields in which they are being trained. At the same time, funding for research is drying up and the pace of progress in the field is slowing. If these are all related, it’s time to re-think how we are investing in the future.

The AP U.S. History test’s largest customer says “no thanks” to the controversial recent revisions.

President Xi is becoming the most powerful Chinese leader since Mao’s death. His most effective tools: selectively prosecuting foreign firms and the corrupt Chinese officials they bribe.

The Ukrainian President’s pleas for arms and a special ally status before Congress have been rebuffed by the Obama Administration. By making it so obvious that his ultimate priority is avoiding a U.S.-Russia confrontation, the President may actually make conflict more likely.

The Houthi rebel group is marching on Sana’a. Their gains, with Iranian backing, are rapidly turning Yemen into a new front of the Shia-Sunni wars.

Efforts to fight Ebola, tragically, tend to undermine the social trust that is so vital to containing the disease.

Beijing announced a ban on low-grade, high-polluting coal earlier this week, but reports have emerged suggesting that power plants will be exempt from the new restrictions.

The Institute of Medicine has released a new report looking to fix end-of-life care through smarter Medicare reimbursements. But our reluctance to talk about death and dying works against advance planning, and that will be hard to overcome.

The arrest of Russian oil baron Vladimir Yevtushenkov tells us that, sanctions notwithstanding, Putin remains firmly in control of Russia’s oligarch class.

The FTC has had three big wins recently fighting hospital mergers, and the whole industry is getting nervous. Given the way medical monopolies can reduce competition and increase prices, this move is coming not a moment too soon.